Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Jubilant HollisterStier CMOJubilant HollisterStier CMO
VS
Hikma PharmaceuticalsHikma Pharmaceuticals
Jubilant HollisterStier CMO

Jubilant HollisterStier CMO

3525 N. Regal St., Spokane, 99207, US

Last Update: 09/03/2026

View Profile
Between 750 and 799
http://www.jublhs.com
757/1000Fair

Jubilant HollisterStier (JHS) CMO provides comprehensive sterile fill-finish and lyophilization services, ensuring the consistent delivery of high-quality products that meet the needs of global healthcare markets and patients worldwide. With our decades of experience a...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:796
Subsidiaries:13
12-month incidents
0
Known data breaches
0
Attack type number
0
Hikma Pharmaceuticals

Hikma Pharmaceuticals

1 New Burlington Place, London, W1S 2HR, GB

Last Update: 12/09/2026

View Profile
Between 750 and 799
http://www.hikma.com
768/1000Fair

For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospita...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:10,252
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Jubilant HollisterStier CMO

Jubilant HollisterStier CMO

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Hikma Pharmaceuticals

Hikma Pharmaceuticals

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Jubilant HollisterStier CMO in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Hikma Pharmaceuticals in 2026.

Incidents

Incident History - Jubilant HollisterStier CMO (X = Date, Y = Severity)

Jubilant HollisterStier CMO cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Hikma Pharmaceuticals (X = Date, Y = Severity)

Hikma Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Jubilant HollisterStier CMO

Jubilant HollisterStier CMO

Incidents
No explicit notable incidents reported.
Hikma Pharmaceuticals

Hikma Pharmaceuticals

Incidents
No explicit notable incidents reported.

FAQ

Between Jubilant HollisterStier CMO company and Hikma Pharmaceuticals company, which one has the best AI Cybersecurity Score ?
Between Jubilant HollisterStier CMO company and Hikma Pharmaceuticals company, which one has experienced more cyber incidents in the past ?
Between Jubilant HollisterStier CMO company and Hikma Pharmaceuticals company, which one has experienced more cyber incidents this year ?
Between Jubilant HollisterStier CMO company and Hikma Pharmaceuticals company, which one has experienced at least one ransomware attack ?
Between Jubilant HollisterStier CMO company and Hikma Pharmaceuticals company, which one has experienced at least one data breach ?
Between Jubilant HollisterStier CMO company and Hikma Pharmaceuticals company, which one has experienced at least one targeted cyberattack ?
Between Jubilant HollisterStier CMO company and Hikma Pharmaceuticals company, which one has experienced at least one vulnerability ?
Between Jubilant HollisterStier CMO company and Hikma Pharmaceuticals company, which one holds the most compliance certifications ?
Between Jubilant HollisterStier CMO company and Hikma Pharmaceuticals company, which one holds the fewest compliance certifications ?
Between Jubilant HollisterStier CMO company and Hikma Pharmaceuticals company, which one has the most subsidiaries ?
Between Jubilant HollisterStier CMO company and Hikma Pharmaceuticals company, which one has the largest number of employees ?
Between Jubilant HollisterStier CMO and Hikma Pharmaceuticals, which company holds both SOC 2 Type 1 certifications ?
Between Jubilant HollisterStier CMO and Hikma Pharmaceuticals, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Jubilant HollisterStier CMO or Hikma Pharmaceuticals ?
Which company is PCI DSS compliant - Jubilant HollisterStier CMO or Hikma Pharmaceuticals ?
Between Jubilant HollisterStier CMO and Hikma Pharmaceuticals, which company complies with HIPAA regulations for healthcare data ?
Between Jubilant HollisterStier CMO and Hikma Pharmaceuticals, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-113705
SUMMARY

A vulnerability was determined in a2aproject a2a-rs up to 0.4.3. This issue affects some unknown processing of the file a2a-server/src/error.rs. Executing a manipulation can lead to information exposure through error message. The attack can be executed remotely. This patch is called 713b943af94ab2d521d483b841618b97a2e78a4d. A patch should be applied to remediate this issue.

PUBLISHED
Date2026-10-20
UPDATED
Date2026-10-20
RISK INFORMATION (Score: 5.3)
CVSS2
Base Score: 5.0
Complexity: LOW
AV:N/AC:L/Au:N/C:P/I:N/A:N
CVSS3
Base Score: 5.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
CVSS4
Base Score: 6.9
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
3.9
CVE-2026-9825
SUMMARY

IBM Cyber Fraud 1.0.0 through 1.0.2 has a missing secure attribute allowing sensitive cookies to be transmitted over unencrypted connections, potentially enabling an attacker to intercept session data through network-based attacks.

PUBLISHED
Date2026-10-20
UPDATED
Date2026-10-20
RISK INFORMATION (Score: 3.7)
CVSS3
Base Score: 3.7
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:L/I:N/A:N
IMPACT SCORE
1.4
EXPLOITABILITY
2.2
CVE-2026-94402
SUMMARY

IBM Carbon Charts 0.4.0 through 1.27.19 is vulnerable to cross-site scripting. The MeterChart component's Title.truncateTitle() function re-inserts a substring of user-supplied label text into the DOM via an unsanitized innerHTML write when the title exceeds the available container width. A remote attacker could exploit this vulnerability to execute arbitrary JavaScript in the victim's browser session.

PUBLISHED
Date2026-10-20
UPDATED
Date2026-10-20
RISK INFORMATION (Score: 6.1)
CVSS3
Base Score: 6.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
IMPACT SCORE
2.7
EXPLOITABILITY
2.8
CVE-2026-93888
SUMMARY

IBM Sterling Connect Direct for Unix 6.4.0.0 through 6.4.0.6 and 6.3.0.0 through 6.3.0.7 apnotify utility is vulnerable to a code injection due to insufficient validation of user input.

PUBLISHED
Date2026-10-20
UPDATED
Date2026-10-20
RISK INFORMATION (Score: 7.8)
CVSS3
Base Score: 7.8
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
1.8
CVE-2026-93744
SUMMARY

IBM i 7.3, 7.4, 7.5, and 7.6 could allow an unathenticated remote attacker to bypass security restrictions due to improper access control. By sending a specially crafted HTTP request to any URL within the Navigator application prior to authentication, a bad actor could exploit this vulnerability to alter server-side session security state.

PUBLISHED
Date2026-10-20
UPDATED
Date2026-10-20
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N
IMPACT SCORE
2.5
EXPLOITABILITY
3.9